Sanofi EBITDA 2010-2024 | SNY

Sanofi EBITDA for the quarter ending June 30, 2024 was $1.429B, a 29.92% decline year-over-year.

  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.
  • Sanofi 2021 EBITDA was 13.81B, a 32.95% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Sanofi EBITDA 2010-2024 | SNY

  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.
  • Sanofi 2021 EBITDA was 13.81B, a 32.95% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Innoviva (INVA)$1.2B